2003 Publications

Aaby, P; Jensen, H; Samb, B; Cisse, B; Sodemann, M; Jakobsen, M; Poulsen, A; Rodrigues, A; Lisse, IM; Simondon, F; +1 more… (2003) Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet, 361 (9376). pp. 2183-2188. ISSN 0140-6736 DOI: 10.1016/S0140-6736(03)13771-3


Abebe, A; Nokes, DJ; Dejene, A; Enquselassie, F; Messele, T; Cutts, FT; (2003) Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiology and infection, 131 (1). pp. 757-770. ISSN 0950-2688 DOI: 10.1017/s0950268803008574


Ali, M; Canh, DG; Clemens, JD; Park, JK; von Seidlein, L; Thiem, VD; Tho le, H; Trach, DD; (2003) The vaccine data link in Nha Trang, Vietnam: a progress report on the implementation of a database to detect adverse events related to vaccinations. Vaccine, 21 (15). pp. 1681-6. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00633-3


Alloueche, A; Milligan, P; Conway, DJ; Pinder, M; Bojang, K; Doherty, T; Tornieporth, N; Cohen, J; Greenwood, BM; (2003) Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. The American journal of tropical medicine and hygiene, 68 (1). pp. 97-101. ISSN 0002-9637


Armah, GE; Steele, AD; Binka, FN; Esona, MD; Asmah, RH; Anto, F; Brown, D; Green, J; Cutts, F; Hall, A; (2003) Changing patterns of rotavirus genotypes in ghana: emergence of human rotavirus G9 as a major cause of diarrhea in children.Journal of clinical microbiology, 41 (6). pp. 2317-22. ISSN 0095-1137 DOI: 10.1128/jcm.41.6.2317-2322.2003


Aylward, RB; Acharya, A; England, S; Agocs, M; Linkins, J; (2003) Global health goals: lessons from the worldwide effort to eradicate poliomyelitis. Lancet, 362 (9387). pp. 909-14. ISSN 0140-6736 DOI: 10.1016/S0140-6736(03)14337-1


Brisson, M; Edmunds, WJ; (2003) Economic evaluation of vaccination programs: the impact of herd-immunity. Medical decision making , 23 (1). pp. 76-82. ISSN 0272-989X DOI: 10.1177/0272989X02239651


Brisson, M; Edmunds, WJ; (2003) Epidemiology of Varicella-Zoster Virus in England and Wales. Journal of medical virology, 70 Suppl 1. S9-14. ISSN 0146-6615 DOI: 10.1002/jmv.10313


Brisson, M; Edmunds, WJ; (2003) Varicella vaccination in England and Wales: cost-utility analysis. Archives of disease in childhood, 88 (10). pp. 862-9. ISSN 0003-9888 DOI: 10.1136/adc.88.10.862


Brisson, M; Edmunds, WJ; Gay, NJ; (2003) Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.Journal of medical virology, 70 Suppl 1. S31-7. ISSN 0146-6615 DOI: 10.1002/jmv.10317


Carabin, H; Edmunds, WJ; (2003) Future savings from measles eradication in industrialized countries. The Journal of infectious diseases, 187 Suppl 1. S29-35. ISSN 0022-1899 DOI: 10.1086/368038


Carabin, H; Edmunds, WJ; Gyldmark, M; Beutels, P; Levy-Bruhl, D; Salo, H; Griffiths, UK; (2003) The cost of measles in industrialised countries. Vaccine, 21 (27-30). pp. 4167-77. ISSN 0264-410X DOI: 10.1016/S0264-410X(03)00534-6


Couper, KN; Nielsen, HV; Petersen, E; Roberts, F; Roberts, CW; Alexander, J; (2003) DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine, 21 (21-22). pp. 2813-20. ISSN 0264-410X DOI: 10.1016/S0264-410X(03)00163-4


Crook, PD; Jones, ME; Hall, AJ; (2003) Mortality of hepatitis B surface antigen-positive blood donors in England and Wales.International journal of epidemiology, 32 (1). pp. 118-24. ISSN 0300-5771 DOI: 10.1093/ije/dyg039


Cumberland, P; Sethi, D; Roderick, PJ; Wheeler, JG; Cowden, JM; Roberts, JA; Rodrigues, LC; Hudson, MJ; Tompkins, DS; (2003) The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode. Epidemiology and infection, 130 (3). pp. 453-60. ISSN 0950-2688 DOI:10.1017/S0950268803008410


Cutts, FT; Fine, PE; (2003) Caution–mortality ratios ahead. Lancet, 361 (9376). pp. 2169-70. ISSN 0140-6736 DOI:10.1016/S0140-6736(03)13783-X


Dourado, I; Rios, MH; Pereira, SMM; Cunha, SS; Ichihara, MY; Goes, JCL; Rodrigues, LC; Bierrenbach, AL; Barreto, ML; (2003) Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren. The international journal of tuberculosis and lung disease , 7 (4). pp. 399-402. ISSN 1027-3719


Enquselassie, F; Ayele, W; Dejene, A; Messele, T; Abebe, A; Cutts, FT; Nokes, DJ; (2003) Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination. Epidemiology and infection, 130 (3). pp. 507-19. ISSN 0950-2688 DOI: 10.1017/s0950268803008446


Fine, PE; (2003) Commentary: Non-specific effects of measles vaccine–more grist for the mill. International journal of epidemiology, 32 (1). pp. 116-7. ISSN 0300-5771 DOI: 10.1093/ije/dyg031


Foynes, S; Holley, JL; Garmory, HS; Titball, RW; Fairweather, NF; (2003) Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F HC fragment. Vaccine, 21 (11-12). pp. 1052-1059. ISSN 0264-410X DOI: 10.1016/S0264-410X(02)00622-9


French, N; (2003) Use of pneumococcal polysaccharide vaccines: no simple answers. The Journal of infection, 46 (2). pp. 78-86. ISSN 0163-4453 DOI: 10.1053/jinf.2002.1113


Garmory, HS; Griffin, KF; Brown, KA; Titball, RW; (2003) Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Vaccine, 21 (21-22). pp. 3051-3057. ISSN 0264-410X DOI: 10.1016/s0264-410x(03)00112-9


Garmory, HS; Leary, SE; Griffin, KF; Williamson, ED; Brown, KA; Titball, RW; (2003) The use of live attenuated bacteria as a delivery system for heterologous antigens. Journal of drug targeting, 11 (8-10). pp. 471-9. ISSN 1061-186X DOI:10.1080/10611860410001670008


Greenwood, B; (2003) Maternal immunisation in developing countries. Vaccine, 21 (24). pp. 3436-41. ISSN 0264-410X DOI: 10.1016/s0264-410x(03)00346-3


Hall, AJ; (2003) Vaccination politics. Tropical medicine & international health , 8 (1). pp. 1-2. ISSN 1360-2276 DOI:10.1046/j.1365-3156.2003.00985.x


Hall, AJ; Wild, CP; (2003) Liver cancer in low and middle income countries – Prevention should target vaccination, contaminated needles, and aflatoxins. BMJ (Clinical research ed), 326 (7397). pp. 994-995. ISSN 0959-8138 DOI:10.1136/bmj.326.7397.994


Hoveyda, N; Behrens, R; (2003) More travel advice and fewer vaccinations are needed. BMJ, 326 (7379). p. 52. ISSN 1468-5833


Jaffar, S; Leach, A; Smith, PG; Cutts, F; Greenwood, B; (2003) Effects of misclassification of causes of death on the power of a trial to assess the efficacy of a pneumococcal conjugate vaccine in The Gambia. International journal of epidemiology, 32 (3). pp. 430-436. ISSN 0300-5771 DOI: 10.1093/ije/dyg082


Jansen, VA; Stollenwerk, N; Jensen, HJ; Ramsay, ME; Edmunds, WJ; Rhodes, CJ; (2003) Measles outbreaks in a population with declining vaccine uptake. Science (New York, NY), 301 (5634). p. 804. ISSN 0036-8075 DOI:10.1126/science.1086726


Kamil, AA; Khalil, EAG; Musa, AM; Modabber, F; Mukhtar, MM; Ibrahim, ME; Zijlstra, EE; Sacks, D; Smith, PG; Zicker, F; +1 more… (2003) Alum-precipitated autoclaved leishmania major plus bacille calmette-guerrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97 (3). p. 365. ISSN 0035-9203 DOI: 10.1016/S0035-9203(03)90171-4


Mangtani, P; Cutts, F; Hall, AJ; (2003) Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. The Lancet infectious diseases, 3 (2). pp. 71-8. ISSN 1473-3099 DOI: 10.1016/S1473-3099(03)00514-0


Morgan, OW; Meltzer, M; Muir, D; Hogan, H; Seng, C; Hill, J; Beckford, J; (2003) Specialist vaccination advice and pockets of resistance to MMR vaccination: lessons from an outbreak of measles. Communicable disease and public health / PHLS, 6 (4). pp. 330-3. ISSN 1462-1843


Nardone, A; Pebody, RG; van Den Hof, S; Levy-Bruhl, D; Plesner, AM; Rota, MC; Tischer, A; Andrews, N; Berbers, G;Crovari, P; +4 more… (2003) Sero-epidemiology of mumps in western Europe. Epidemiology and infection, 131 (1). pp. 691-701. ISSN 0950-2688 DOI: 10.1017/S0950268803008768


O’Brien, KL; Nohynek, H; World Health Organization Pneumococcal Vaccine Trials Carraige W; (2003) Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. The Pediatric infectious disease journal, 22 (2). pp. 133-40. ISSN 0891-3668 DOI: 10.1097/01.inf.0000048676.93549.d1


Pantosti, A; Boccia, D; D’Ambrosio, F; Recchia, S; Orefici, G; Moro, ML; (2003) Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases. Microbial drug resistance (Larchmont, NY), 9 Suppl 1. S61-8. ISSN 1076-6294 DOI:10.1089/107662903322541919


Perrett, K; Granerod, J; Crowcroft, N; Carlisle, R; (2003) Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug users? Communicable disease and public health / PHLS, 6 (2). pp. 97-100. ISSN 1462-1843


Rhodes, SD; Yee, LJ; Hergenrather, KC; (2003) Hepatitis A vaccination among young African American men who have sex with men in the deep south: psychosocial predictors. Journal of the National Medical Association, 95 (4 Suppl). 31S-36S. ISSN 0027-9684


Roy, P; (2003) Nature and duration of protective immunity to bluetongue virus infection. Developments in biologicals, 114. pp. 169-83. ISSN 1424-6074


Russell, FM; Carapetis, JR; Mansoor, O; Darcy, A; Fakakovi, T; Metai, A; Potoi, NT; Wilson, N; Mulholland, EK; (2003) High incidence of Haemophilus influenzae type b infection in children in Pacific island countries. Clinical infectious diseases , 37 (12). pp. 1593-9. ISSN 1058-4838 DOI: 10.1086/379717


Vynnycky, E; Gay, NJ; Cutts, FT; (2003) The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome. Vaccine, 21 (21-22). pp. 2708-2719. ISSN 0264-410X DOI: 10.1016/S0264-410X(03)00229-9